Advertisement
UK markets close in 24 minutes
  • FTSE 100

    8,041.57
    -3.24 (-0.04%)
     
  • FTSE 250

    19,717.65
    -82.07 (-0.41%)
     
  • AIM

    754.52
    -0.35 (-0.05%)
     
  • GBP/EUR

    1.1634
    +0.0006 (+0.05%)
     
  • GBP/USD

    1.2438
    -0.0015 (-0.12%)
     
  • Bitcoin GBP

    52,311.30
    -1,369.39 (-2.55%)
     
  • CMC Crypto 200

    1,410.18
    -13.92 (-0.98%)
     
  • S&P 500

    5,061.93
    -8.62 (-0.17%)
     
  • DOW

    38,374.71
    -128.98 (-0.33%)
     
  • CRUDE OIL

    82.92
    -0.44 (-0.53%)
     
  • GOLD FUTURES

    2,342.30
    +0.20 (+0.01%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,076.28
    -61.37 (-0.34%)
     
  • CAC 40

    8,082.78
    -23.00 (-0.28%)
     

A Look At AstraZeneca’s Research Pipeline

A Look At AstraZeneca’s Research Pipeline

Investors have a lot to watch for in AstraZeneca’s (AZN) research pipeline in the second fiscal quarter. The company expects a data readout for Lynparza in an ovarian cancer indication. A regulatory decision is expected for Tagrisso in the European Union for lung cancer.